These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24259050)

  • 1. Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR.
    Rottiers V; Obad S; Petri A; McGarrah R; Lindholm MW; Black JC; Sinha S; Goody RJ; Lawrence MS; deLemos AS; Hansen HF; Whittaker S; Henry S; Brookes R; Najafi-Shoushtari SH; Chung RT; Whetstine JR; Gerszten RE; Kauppinen S; Näär AM
    Sci Transl Med; 2013 Nov; 5(212):212ra162. PubMed ID: 24259050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.
    Bernardo BC; Gao XM; Winbanks CE; Boey EJ; Tham YK; Kiriazis H; Gregorevic P; Obad S; Kauppinen S; Du XJ; Lin RC; McMullen JR
    Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17615-20. PubMed ID: 23047694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LNA-mediated microRNA silencing in non-human primates.
    Elmén J; Lindow M; Schütz S; Lawrence M; Petri A; Obad S; Lindholm M; Hedtjärn M; Hansen HF; Berger U; Gullans S; Kearney P; Sarnow P; Straarup EM; Kauppinen S
    Nature; 2008 Apr; 452(7189):896-9. PubMed ID: 18368051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver.
    Elmén J; Lindow M; Silahtaroglu A; Bak M; Christensen M; Lind-Thomsen A; Hedtjärn M; Hansen JB; Hansen HF; Straarup EM; McCullagh K; Kearney P; Kauppinen S
    Nucleic Acids Res; 2008 Mar; 36(4):1153-62. PubMed ID: 18158304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of microRNA families by seed-targeting tiny LNAs.
    Obad S; dos Santos CO; Petri A; Heidenblad M; Broom O; Ruse C; Fu C; Lindow M; Stenvang J; Straarup EM; Hansen HF; Koch T; Pappin D; Hannon GJ; Kauppinen S
    Nat Genet; 2011 Mar; 43(4):371-8. PubMed ID: 21423181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNAs in lipoprotein metabolism and cardiometabolic disorders.
    Rotllan N; Price N; Pati P; Goedeke L; Fernández-Hernando C
    Atherosclerosis; 2016 Mar; 246():352-60. PubMed ID: 26828754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases.
    Ooi JYY; Bernardo BC; Singla S; Patterson NL; Lin RCY; McMullen JR
    RNA Biol; 2017 May; 14(5):500-513. PubMed ID: 27124358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Gastric Tumor Cell Growth Using Seed-targeting LNA as Specific, Long-lasting MicroRNA Inhibitors.
    Staedel C; Varon C; Nguyen PH; Vialet B; Chambonnier L; Rousseau B; Soubeyran I; Evrard S; Couillaud F; Darfeuille F
    Mol Ther Nucleic Acids; 2015 Jul; 4(7):e246. PubMed ID: 26151747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEI-complexed LNA antiseeds as miRNA inhibitors.
    Thomas M; Lange-Grünweller K; Dayyoub E; Bakowsky U; Weirauch U; Aigner A; Hartmann RK; Grünweller A
    RNA Biol; 2012 Aug; 9(8):1088-98. PubMed ID: 22894918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.
    Rayner KJ; Esau CC; Hussain FN; McDaniel AL; Marshall SM; van Gils JM; Ray TD; Sheedy FJ; Goedeke L; Liu X; Khatsenko OG; Kaimal V; Lees CJ; Fernandez-Hernando C; Fisher EA; Temel RE; Moore KJ
    Nature; 2011 Oct; 478(7369):404-7. PubMed ID: 22012398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma.
    Kunz M; Brandl M; Bhattacharya A; Nobereit-Siegel L; Ewe A; Weirauch U; Hering D; Reinert A; Kalwa H; Guzman J; Weigelt K; Wach S; Taubert H; Aigner A
    J Nanobiotechnology; 2020 Nov; 18(1):173. PubMed ID: 33228711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of microRNAs for therapeutics.
    Stenvang J; Lindow M; Kauppinen S
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1197-200. PubMed ID: 19021524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of MicroRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage Cholesterol Efflux in Vitro and in Vivo.
    Nguyen MA; Wyatt H; Susser L; Geoffrion M; Rasheed A; Duchez AC; Cottee ML; Afolayan E; Farah E; Kahiel Z; Côté M; Gadde S; Rayner KJ
    ACS Nano; 2019 Jun; 13(6):6491-6505. PubMed ID: 31125197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual microRNAs (miRNAs) display distinct mRNA targeting "rules".
    Wang WX; Wilfred BR; Xie K; Jennings MH; Hu YH; Stromberg AJ; Nelson PT
    RNA Biol; 2010; 7(3):373-80. PubMed ID: 20421741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice.
    Okada H; Honda M; Campbell JS; Takegoshi K; Sakai Y; Yamashita T; Shirasaki T; Takabatake R; Nakamura M; Tanaka T; Kaneko S
    Cancer Sci; 2015 Sep; 106(9):1143-52. PubMed ID: 26122702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression.
    Murphy BL; Obad S; Bihannic L; Ayrault O; Zindy F; Kauppinen S; Roussel MF
    Cancer Res; 2013 Dec; 73(23):7068-78. PubMed ID: 24145352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Inhibition of miR-130 Family Suppresses Bladder Tumor Growth by Targeting Various Oncogenic Pathways via PTPN1.
    Monoe Y; Jingushi K; Kawase A; Hirono T; Hirose R; Nakatsuji Y; Kitae K; Ueda Y; Hase H; Abe Y; Adachi J; Tomonaga T; Tsujikawa K
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient 3'-pairing renders microRNA targeting less sensitive to mRNA seed accessibility.
    Kosek DM; Banijamali E; Becker W; Petzold K; Andersson ER
    Nucleic Acids Res; 2023 Nov; 51(20):11162-11177. PubMed ID: 37819016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA Seed Region Length Impact on Target Messenger RNA Expression and Survival in Colorectal Cancer.
    Mullany LE; Herrick JS; Wolff RK; Slattery ML
    PLoS One; 2016; 11(4):e0154177. PubMed ID: 27123865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA Targeting of Oxysterol-Binding Protein-Like 6 Regulates Cholesterol Trafficking and Efflux.
    Ouimet M; Hennessy EJ; van Solingen C; Koelwyn GJ; Hussein MA; Ramkhelawon B; Rayner KJ; Temel RE; Perisic L; Hedin U; Maegdefessel L; Garabedian MJ; Holdt LM; Teupser D; Moore KJ
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):942-951. PubMed ID: 26941018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.